KANG Wei
School
School of Pharmaceutical Science and Technology
Professional Title
Associate professor
Discipline
Real-world Evidence and Medical Big Data Analysis
Contact Information
weikang@tju.edu.cn
Education Background
- Doctoral degree| The University of Hong Kong| Pharmacology and Pharmacy| 2025
- Master’s Degree| China Pharmaceutical University| Microbial and Biochemical Pharmacy| 2016
- Bachelor’s Degree| China Pharmaceutical University| Biotechnology| 2013
Research Interests
- Real-world Evidence and Medical Big Data Analysis
- Pharmacoeconomics
- Pharmacoepidemiology
Positions & Employments
-
2025.9-Now
School of Pharmaceutical Science and Technology | Tianjin University | Associate Professor -
2025.5-2025.9
AI and Pharmaceuticals in Non-Communicable Diseases (NCDs) | Laboratory of Data Discovery for Health (D24H) | Post-doctoral Fellow -
2025.1-2025.4
AI and Pharmaceuticals in Non-Communicable Diseases (NCDs) | Laboratory of Data Discovery for Health (D24H) | Research Assistant
Academic Achievements
- Papers
- [1] Kang, W.*, Shen, C. Y.*, Cheng, M. C., Yan, V. K. C., Lee, S. F., Chung, W. P., Huang, C., Li, S. T. H., Wei, Y., Lee, V. H. F., Chan, S. L., Lam, K. O., El Helali, A., Lai, E. C., & Chan, E. W. (2026). Switching Cancer-associated Venous Thromboembolism Treatment from Continuous LMWH to DOACs: An Evaluation. Thromb Haemost. https://doi.org/10.1055/a-2785-8686
- [2] Kang, W., Huang, C., Yan, V. K. C., Wei, Y., Shami, J. J. P., Li, S. T. H., Yang, Y., Ye, X., Tang, J., Lee, S. F., Lee, V. H. F., Chan, S. L., El Helali, A., Lam, K. O., Ngan, R. K. C., Wong, I. C. K., & Chan, E. W. (2024). Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis. Nat Commun, 15(1), 5657. https://doi.org/10.1038/s41467-024-50037-1
-
- [3] Kang, W.*, Shami, J. J. P.*, Yan, V. K. C., Ye, X., Blais, J. E., Li, X., Lee, V. H. F., Chui, C. S. L., Lai, F. T. T., Wan, E. Y. F., Wong, C. K. H., Wong, I. C. K., & Chan, E. W. (2022). Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study. Journal of Hematology & Oncology, 15(1), 66.
- [4] Kang, W., Peng, K., Yan, V. K. C., Al-Badriyeh, D., Lee, S. F., Yiu, E. H. H., Wei, Y., Li, S. T. H., Ye, X., Helali, A. EI., Lam, K., Lee, V. H. F., Wong, I. C. K., & Chan, E. W. (2024). Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thromboembolism: A Cost-effectiveness Analysis. Journal of Pharmaceutical Policy and Practice, 17(1), 2375269.
- [5] Wei, Y., Yan, V. K. C., Kang, W., Wong, I. C. K., Castle, D. J., Gao, L., Chui, C. S. L., Man, K. K. C., Hayes, J. F., Chang, W. C., & Chan, E. W. (2022). Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia. JAMA Netw Open, 5(7), e2224163. https://doi.org/10.1001/jamanetworkopen.2022.24163
- [6] Huang, C.*, Wei, Y.*, Yan, V. K. C., Ye, X., Kang, W., Yiu, H. H. E., Shami, J. J. P., Cowling, B. J., Tse, M. L., Castle, D. J., Chui, C. S. L., Lai, F. T. T., Li, X., Wan, E. Y. F., Wong, C. K. H., Hayes, J. F., Chang, W. C., Chung, A. K. K., Lau, C. S., . . . Chan, E. W. (2023). Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study. Lancet Psychiatr
- [7] Ye, X.*, Ma, T.*, Blais, J. E., Yan, V. K. C., Kang, W., Chui, C. S. L., Lai, F. T. T., Li, X., Wan, E. Y. F., Wong, C. K. H., Tse, H. F., Siu, C. W., Wong, I. C. K., & Chan, E. W. (2022). Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease. Cardiovasc Res, 118(10), 2329-2338. https://doi.org/10.1093/cvr/cvac068
- [8] Yiu, H. H. E., Chow, L. H., Au, C. C. L., Deng, E. K., Zhao, Z., Wei, Y., Lee, K. J., Huang, C., Yang, Y., Kang, W., Petrou, S., Madan, J., & Chan, E. W. (2025). A think-aloud study exploring the application of composite time trade-off and discrete choice experiment methods for valuing the Chinese Short Warwick-Edinburgh Mental Well-being Scale (C-SWEMWBS). Health and Quality of Life Outcomes, 23(1). https://doi.org/10.1186/s12955-025-02433-4
- [9] Ye, X.*, Blais, J. E.*, Ng, V. W. S., Castle, D., Hayes, J. F., Wei, Y., Kang, W., Gao, L., Yan, V. K. C., Wong, I. C. K., & Chan, E. W. (2023). Association between statins and the risk of suicide attempt, depression, anxiety, and seizure: A population-based, self-controlled case series study. J Affect Disord, 320, 421-427. https://doi.org/10.1016/j.jad.2022.09.148
- [10] Ye, X., Huang, C., Yan, V. K. C., Kang, W., Fan, M., Tsang, G. K. C., Ho, C. M. Y., Lip, G. Y. H., Yiu, K. H., Tse, H. F., Ma, T., Qin, X., Chui, C. S. L., Lai, F. T. T., Wong, C. K. H., Wan, E. Y. F., Li, X., Lee, C. K., Hung, I. F. N., . . . Chan, E. W. Y. (2023). Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study. Eur Heart J Ca
- [11] Ye, X.*, Yan, V. K. C.*, Yiu, H. H. E., Shami, J. J. P., Kang, W., Ma, T., Qin, X., Chui, C. S. L., Lai, F. T. T., Li, X., Wan, E. Y. F., Wong, C. K. H., Wong, I. C. K., & Chan, E. W. (2023). BNT162b2 or CoronaVac Vaccinations Are Associated With a Lower Risk of Myocardial Infarction and Stroke After SARS-CoV-2 Infection Among Patients With Cardiovascular Disease. J Am Heart Assoc, 12(9), e029291. https://doi.org/10.1161/JAHA.122.029291
- [12] Ye, X., Shami, J. J. P., Yan, V. K. C., Kang, W., Blais, J. E., Zhao, J., Lau, W. C. Y., Wei, L., Wong, I. C. K., & Chan, E. W. (2021). Global antiplatelet sales trend: A focus on P2Y12 inhibitors from 2008 to 2018. Am Heart J Plus, 4, 100020. https://doi.org/10.1016/j.ahjo.2021.100020
- [13] Kang, W.*, Liu, H.*, Ma, L., Wang, M., Wei, S., Sun, P., Jiang, M., Guo, M., Zhou, C., & Dou, J. (2017). Effective antimicrobial activity of a peptide mutant Cbf-14-2 against penicillin-resistant bacteria based on its unnatural amino acids. Eur J Pharm Sci, 105, 169-177. https://doi.org/10.1016/j.ejps.2017.05.030
- [14] Li, B.*, Kang, W.*, Liu, H., Wang, Y., Yu, C., Zhu, X., Dou, J., Cai, H., & Zhou, C. (2016). The antimicrobial activity of Cbf-K16 against MRSA was enhanced by beta-lactamantibiotics through cell wall non-integrity. Arch Pharm Res, 39(7), 978-988. https://doi.org/10.1007/s12272-016-0769-x
- [15] Ma, L., Wang, Y., Wang, M., Tian, Y., Kang, W., Liu, H., Wang, H., Dou, J., & Zhou, C. (2016). Effective antimicrobial activity of Cbf-14, derived from a cathelin-like domain, against penicillin-resistant bacteria. Biomaterials, 87, 32-45. https://doi.org/10.1016/j.biomaterials.2016.02.011